TNFRSF9 and infection: Furthermore, CD137+ Vγ9Vδ2-T cell treatment showed a better ability to reduce virus titers in the lungs of infected mice by day 8 post infection than either CD137− T cells or whole Vγ9Vδ2-T cells (Fig. 3e).